PLB-015
N/A
Report date: 2026/05/15 16:30:16
Base Information
Drug NamePLB-015
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesPrimeLink BioTherapeutics
China Registration ClassN/A
Develop Information
Active CompaniesPrimeLink BioTherapeutics
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A